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Mutations of the gene encoding myosin V can produce
a dilute or silvery hair color and various neurologic
defects in mice and patients with Griscelli syndrome,
leading to speculations that the myosin V motor protein
plays a critical role in transporting melanosomes within
melanocytes and neurosecretory vesicles within neurons.
Therefore, we investigated the in vitro expression of
myosin V in cultured normal human melanocytes, ker-
atinocytes, and dermal fibroblasts using reverse tran-
scriptase-polymerase chain reaction and northern blot
analysis. Subcellular distribution of myosin V and
proximity to actin bundles and melanosomes were deter-
mined by double indirect immunofluorescence labeling
and immunogold electron microscopy. In all studied cells
Very little is known about the molecular mechanismsunderlying dendrite extension and melanosome transportin human melanocytes. It is expected that cytoskeletalproteins such as actin and microtubule components withtheir respective motor proteins play a role in these
processes. Indeed, Lacour et al (1992) reported that actin microfilaments
play a role in dendrite formation and microtubules play a role in
dendrite maintenance in cultured human melanocytes.
Myosin V is an actin-activated ATPase, a type of motor protein
representing the fifth of 13 classes of unconventional myosins (for
reviews see Mooseker, 1993; Hammer, 1994; Mooseker and Cheney,
1995; Hasson and Mooseker, 1996, 1997b; Titus, 1997a; Baker and
Titus, 1998). The first group of myosin V members is encoded by the
yeast myo2/myo4 genes (Govindan et al, 1995), the mouse dilute gene
(Mercer et al, 1991), the chicken p190 gene (Espreafico et al, 1992),
and the human myoxin gene (Engle and Kennett, 1994; Moore et al,
1995). Recently, myr 6, a second group of the myosin V family, was
cloned and characterized in rat (Zhao et al, 1996). Structurally, myosin
V is a two-headed, nonfilamentous protein consisting of an N-terminal
head domain containing actin-binding and ATP-hydrolysis sites, a neck
domain with six IQ motifs that bind calmodulin/light chains and a tail
domain consisting of a coiled-coil stalk and a carboxy-terminal globular
Manuscript received November 11, 1997; revised July 17, 1998; accepted
for publication July 27, 1998.
Reprint requests to: Dr. Jean Marie Naeyaert, Department of Dermatology,
University Hospital, De Pintelaan 185, 9000 Gent, Belgium.
Abbreviation: IBMX, 3-isobutyl-1-methylxanthine.
0022-202X/98/$10.50 · Copyright © 1998 by The Society for Investigative Dermatology, Inc.
835
myosin V is expressed and treatment of melanocytes with
the cyclic AMP-inducer 3-isobutyl-1-methylxanthine
causes an induction of the myosin V message. In all cells
myosin V colocalizes with actin bundles, concentrating
in the subcortical cell zone. In the melanocyte it is closely
associated with melanosomes. Quantitative analysis of
myosin V labeling in melanocytes reveals a significantly
higher (p < 0.005) presence of myosin V in the periphery
of dendrites. These results suggest that myosin V is
important in melanosome transport in human melano-
cytes. Possible roles in the other skin cells remain to be
elucidated. Key words: cytoskeleton/dendritogenesis/melano-
some movement. J Invest Dermatol 111:835–840, 1998
domain that is thought to bind myosin to organelles (Cheney et al,
1993; Nascimento et al, 1996).
Yeast myo2 gene mutations result in large, unbudding cells that pack
vesicles in their cytoplasm. The originally described mouse dilute locus
mutations termed dilute-viral (dv) cause a dilution of coat color (Silvers,
1979). Other more severe dilute alleles (dilute-lethal, dL) also produce
neurologic defects with seizures, opisthotonus, and death at early age
(Mercer et al, 1991). The human autosomal recessive Griscelli–Prunie´ras
syndrome (Griscelli et al, 1978) is characterized by partial albinism with
silvery-blond hair discoloration, primary immunodeficiency, and severe
neurologic disorders, with death occurring in the first decades of life.
Recently, mutations in the myosin V gene of two Griscelli patients
were reported by Pastural et al (1997). Initially, the pigment disorder
seen in humans and mice was thought to be due to underdeveloped
melanocyte dendrites, but recent findings (Provance et al, 1996; Wei
et al, 1997) have shown that dilute melanocytes do not lack dendrites
but display defective melanosome transport into these dendrites. These
phenotypic findings have led to the hypothesis that class V myosins
play a role in organelle transport or membrane dynamics. Govindan
et al (1995) suggest that yeast myo2 plays a role in transporting secretory
vesicles from the mother cell along actin cables into the bud. Myosin
V is abundantly present in neurons (Mercer et al, 1991), where it may
participate in organelle transport along actin filament bundles in rat
neuroneal growth cones (Evans and Bridgman, 1995; Evans et al, 1997;
Prekeris and Terrian, 1997). Wang et al (1996) suggest a role for myosin
V in filopodial extension in growth cones of chick dorsal root ganglion
neurons, whereas Evans et al (1997) observed no necessary role of
myosin V in regulating filopodial dynamics in nerve growth cones,
because neurite outgrowth in dilute-lethal mice is normal. As for
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pigment cells, Provance et al (1996) showed that myosin V can be
immunoprecipitated from isolated melanosomes in mice, a finding that
is highly suggestive for actin-based locomotion of melanosomes,
confirmed by light immunofluorescence microscopy and immuno-
electron microscopy by Wu et al (1997).
In this study of the role of myosin V in human melanocytes, we
examine the role of myosin V in dendrite formation and melanosome
transport by looking at myosin V expression and subcellular localization.
Moreover, we investigate its expression in the other cutaneous cells,
keratinocytes, and dermal fibroblasts. We find myosin V to be expressed
in all studied skin cells and, in melanocytes, to be associated with
melanosomes.
MATERIALS AND METHODS
Cell culture Epidermal melanocyte primary cultures were obtained from
neonatal foreskins and established in M199 medium (Gibco BRL, Merelbeke,
Belgium) supplemented with 2% fetal bovine serum, 10–9 M choleratoxin,
10 ng basic fibroblast growth factor per ml, 10 µg insulin per ml, 1.4 µM
hydrocortisone, and 10 µg transferrin per ml as described earlier (Naeyaert et al,
1991). Post-primary cultures were cultured in low calcium (0.03 mM) M199
medium supplemented with the same factors and 10% fetal bovine serum. For
the experiments, third passage melanocytes were cultured for at least 4 d in a
medium free of the cAMP-enhancer choleratoxin as described by Donatien
et al (1993). Briefly, this melanocyte growth medium is composed of two-thirds
MCDB153 and one-third Iscove’s modified Dulbecco’s medium supplemented
with whole bovine pituitary extract (47 µg per ml), epidermal growth factor
(3.3 ng per ml), insulin (3.3 µg per ml), hydrocortisone (0.94 µM), and 3%
fetal bovine serum. For the induction experiments, 100 µM 3-isobutyl-1-
methylxanthine (IBMX) was added to these cultures for 48 h. All chemicals
and growth factors noted here are from Sigma (Bornem, Belgium), except
whole bovine pituitary extract which is available at Gibco BRL (Gent, Belgium).
Cultures of human keratinocytes were initiated from adult skin biopsies and
cultured in growth factor- and serum-supplemented Dulbecco’s modified Eagle’s
medium/Ham’s F12 to near confluency as previously described (Beele et al,
1991). Fibroblasts were established as explants from dermal portions of skin
biopsies and cultured in Optimem I supplemented with 2% Ultroser G and 1%
glutamine (Gibco BRL, Merelbeke, Belgium).
RNA preparation Total cellular RNA was harvested from subconfluent cell
cultures in Tri-reagent (Sigma) and isolated according to the manufacturer’s
instructions. Poly(A)1 RNA was obtained using PolyA Tract mRNA Isolation
System III (Promega, Leiden, The Netherlands). Purity of the obtained total
RNA and mRNA samples was checked by measuring the absorbance ratio at
260/280 nm, which was .1.7 in all samples. Total RNA was DNAse treated
(DNAse I, Promega, Leiden, The Netherlands) prior to use in reverse
transcriptase-polymerase chain reaction (RT-PCR) to eliminate amplification
of genomic DNA.
RT-PCR Approximately 1 µg of total RNA was reverse transcribed with
random primers and amplified using the GeneAmp RNA-PCR kit (Perkin
Elmer, Brussels, Belgium). Two oligonucleotides (P1, 59-TGCACCTGCTTA-
TGGAGAC-39; P2, 59-TTCGCTTCCTCTTCACTTAGT-39) were chosen
defining a 1006 bp cDNA in the neck region of the human myosin V cDNA
(Engle and Kennett, 1994; Genbank accession numbers L19401 or Y07759)
using Oligo 5.0 software. Considering the high probability of sequence overlap
with other myosin sequences (Hasson et al, 1996), the oligonucleotides were
carefully checked for false priming sites in the following published myosin
coding sequences (Genbank): human myosin IB and IE (X98411 and X98507),
human myosin IC gene (U14391), human myosin VI (U90236), human myosin
VIIa (U39226), and human myosin IXb (U42391). False priming sites in human
frequent sequences were excluded as well. PCR amplification conditions were
95°C for 1 min, 60.5°C for 1 min, and 72°C for 1.5 min during 35 cycles
after an initial denaturation at 95°C for 2 min and terminating the reaction
with 7 min at 72°C. cDNA bands were visualized on a 1.5% TAE-agarose
ethidium bromide stained gel. The resulting 1006 bp cDNA was eluted from
the gel (QiaEx gel extraction kit, Westburg, The Netherlands) and after
purification used as a hybridization probe in northern blot.
Northern blot Northern blot was performed as previously described (Wintzen
et al, 1996). Briefly, 2 µg of poly(A)1 RNA was electrophoresed on a 1%
agarose gel containing 2.2 M formaldehyde. RNA was transferred overnight
onto a nylon membrane (Hybond-N1, Amersham, Gent, Belgium) and
immobilized by UV irradiation in a UV-Stratalinker (Stratagene, La Jolla, CA).
Prehybridization of the blot was in a solution containing 50% deionized
formamide, 53Denhardt’s solution, 0.02% sodium dodecyl sulfate, and 0.2 mg
salmon sperm DNA per ml at 45°C during 2 h. The 1006 bp myosin V cDNA
probe was labeled with [32P]-dCTP using Oligolabeling kit (Pharmacia,
Roosendaal, The Netherlands) and hybridized to the blot overnight at 45°C
in a solution containing 50% deionized formamide, 2.5 3 Denhardt’s solution,
0.02% sodium dodecyl sulfate, 5 3 SSPE, and 0.02 mg salmon sperm DNA
per ml together with a radiolabeled G3PDH control probe. Washes were
performed at room temperature once for 5 min and three times for 20 min in
0.3 M NaCl, 0.03 M sodium citrate, 0.1% sodium dodecyl sulfate, and
subsequently twice for 20 min at 45°C and twice at 55°C in 15 mM NaCl,
1.5 mM sodium citrate, 0.1% sodium dodecyl sulfate. Blots were exposed to a
phosphor screen (Molecular Dynamics, Krefeld, Germany) during 48 h and the
digitized images were evaluated densitometrically using Phosphor Imager
Imagequant software.
Indirect immunofluorescence and confocal microscopy Cells were
grown on coverslips and fixed for 20 min at room temperature with 3%
paraformaldehyde in phosphate-buffered saline (PBS). For permeabilization,
cells were treated for 5 min with 0.2% Triton X-100 in PBS. Double staining
for myosin V proteins and actin was performed by incubating for 1 h at room
temperature with a rabbit polyclonal anti-myosin V antibody DIL-2 (1:400)
(Wu et al, 1997). After three washes in TBS, the slides were incubated in a
biotinylated donkey-anti-rabbit antibody (Amersham) 1:50 dilution for 1 h at
room temperature, again washed, and finally incubated in a mixture of
fluorescein isothiocyanate-conjugated phalloidin (Sigma) and streptavidin-texas
red for 30 min at room temperature. For double staining of myosin V and
melanosomes, slides were first incubated for 1 h at room temperature in a 1:40
mouse monoclonal NKI-beteb (Monosan, Uden, The Netherlands) and a 1:400
DIL-2 dilution, followed by a second incubation step of 1 h at room temperature
with an fluorescein isothiocyanate-linked swine-anti-rabbit antibody (1:20) and
a biotinylated sheep anti-mouse antibody (1:50) (both of Prosan, Gent, Belgium)
and a final third incubation step with streptavidin-texas red. Slides were
coverslipped in Prosan fluorescence mounting fluid and confocal images (1 µm
sections) were obtained with a Zeiss laser confocal microscope. For negative
controls incubation with an irrelevant isotype-matched antibody was performed.
The (polyclonal) antibody DIL-2 used in our immunocytochemical experiments
was extensively tested on its specific interaction with a myosin V isoform (raised
against myosin V heavy chain residues 910–1106) encoded by the dilute locus
by its generators (Wu et al, 1997).
Immunoelectron microscopy Confluent cell cultures were fixed for 1 h
at room temperature in 0.1% glutaraldehyde in 0.14 M cacodylate buffer,
pH 7.3, and processed for immunogold labeling as described elsewhere
(Mommaas et al, 1992). Briefly, cells were pelleted and embedded in 10%
gelatin, cut into 1 mm3 cubes, cryoprotected in 2.3 M sucrose for 25 min and
snapfrozen in liquid nitrogen. Ultrathin cryosections were prepared and incub-
ated with the polyclonal rabbit anti-myosin V antibody DIL-2 (cfr. supra)
diluted 1:250, followed by 10 nm protein A-gold. For double labeling with
actin bundles a mouse anti-human actin bundles monoclonal antibody (dilution
1:20) from Chemicon (Biognost, Wevelgem, Belgium) was used and visualized
with 5 nm protein A-gold after an intermediate incubation step with a secondary
rabbit anti-mouse immunoglobulin (Dako, The Netherlands). For negative
controls the primary antibody step was omitted and incubation with an irrelevant
isotype-matched antibody was performed. After immunolabeling, sections were
embedded and contrasted in methylcellulose/uranyl acetate and viewed with a
Philips EM 410 electron microscope.
Image analysis For quantitation of myosin V immunolabeling, immunoelec-
tron microscopy photographs of whole melanocytes (n 5 6) were made at a
final magnification of 55,0003. Four different cell regions were considered
(Fig 1): periphery of the dendrite, center of the dendrite, perinuclear area, and
periphery of the perinuclear area. Periphery of the dendrite and of the
perinuclear area was recognized as a more darkly stained peripheral area of
cytoplasm that represents the 150 nm thick actin subcortical meshwork. The
perinuclear area was defined as the vesicle-rich area surrounding the nucleus.
These cell zones were scored quantitatively by automatical analysis of the
number of myosin V colloidal gold particles per µm2 using Kontron KS400
image processing software. Nuclear labeling was taken as background. Results
obtained for various experimental groups were compared using the nonparamet-
ric Friedman test. p values ,0.05 were considered to be statistically significant.
RESULTS
Myosin V is expressed in skin cells in vitro The three examined
skin cells show the appropriately sized myosin V 1006 bp cDNA band
after RT-PCR (Fig 2). Northern blot analysis (Fig 3a) reveals the
complex transcription pattern of myosin V in all cells with 7, 8, and
12 kb messages as described in the literature (Mercer et al, 1991).
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Figure 1. Schematic presentation of the subdivision of the melanocyte
into four different cytoplasmic regions. 1, perinuclear area; 2, peripheral
perinuclear area; 3, center of the dendrite; 4, periphery of the dendrite.
Figure 2. Myosin V is expressed in normal human skin cells. RNA was
extracted from cultured human melanocytes (lane 2), keratinocytes (lane 3), and
dermal fibroblasts (lane 4) of a normal individual. RNA was reverse transcribed
and amplified by RT-PCR using myosin V-specific primers, resulting in an
appropiately sized myosin V 1006 bp band. Lane 1 represents a 100 bp DNA-
ladder (Gibco BRL, Gent, Belgium) with the more intense band being
500 bp DNA.
Figure 3. Northern blot analysis of different skin cell types reveals
different myosin V transcripts and induction of myosin V in melanocytes
under the influence of IBMX. (a) Melanocytes (lane 1), keratinocytes (lane
2), and dermal fibroblasts (lane 3) have the 7, 8, and 12 kb messages probed
with a [32P]-labeled fragment of human myosin V cDNA PCR product. (b)
Two micrograms mRNA was isolated out of control melanocytes versus IBMX-
treated melanocytes and analyzed by northern blot analysis hybridized for
myosin V and G3PDH. On this representative blot, quantitation of density of
the myosin V bands using a phosphorimager revealed a 5-fold induction of
myosin V after correction for loading differences relative to the G3PDH
mRNA intensity.
Myosin V message is induced in melanocytes after stimulation
of differentiation with IBMX Melanocytes grown in melanocyte
growth medium display a bipolar to tripolar slender cell body. IBMX
(100 µM final concentration) changed the morphology of the bipolar
Figure 4. Indirect immunofluorescence localization of antigen
recognized by the myosin V antibody in melanocytes. Human melanocytes
were cultured on coverslips for 24 h, fixed, and stained with a polyclonal anti-
myosin V antibody. Scale bar: 10 µm.
Figure 5. Double immunofluorescent staining for myosin V and actin.
Human melanocytes were cultured on coverslips for 24 h, fixed, and double
stained with a polyclonal anti-myosin V antibody (texas red signal) and phalloidin
(fluorescein signal). In this confocal photomicrograph, yellow staining (arrows)
indicates the presence of myosin V in the actin-rich subcortical meshwork and
near actin bundles in the perinuclear area. Scale bar: 10 µm.
to tripolar melanocytes towards cells with a higher number of dendrites
(four or more) per cell body within 48 h after addition (not shown).
Dendrites were also generally longer and sometimes highly branched
in the treated melanocytes. Quantitative analysis of the northern
blot (Fig 3b) of control bipolar melanocytes versus highly dendritic
melanocytes showed that the myosin V mRNA level increases up to
5-fold in melanocytes treated with IBMX for 48 h above control
melanocytes.
Myosin V is present throughout the cytoplasm In all cells
studied, myosin V immunofluorescent images reveal a punctate-staining
pattern throughout the cytoplasm with clear intensification in the
perinuclear area and, in melanocytes (Fig 4), throughout the dendrites.
Double labeling of myosin V with actin (Fig 5) shows that in the
melanocyte myosin V colocalizes with subcortical actin. In the central
cytoplasm no well-structured colocalization of myosin V with actin
bundles (e.g., with the focal contacts and stress fibers) can be observed.
Moreover, myosin V staining is accentuated at the tip of each
melanocytic dendrite (Figs 4, 5).
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Figure 6. Melanocytes show immunocolocalization of myosin V with
actin, particularly in the dense subcortical network. Glutaraldehyde-fixed
ultrathin cryosections of cultured human melanocytes were subjected to an
immunogold-labeling procedure with anti-myosin V (10 nm gold particles) and
anti-human actin bundles (5 nm gold particles) antibodies. Colocalization is
most noticeable underneath the cell membrane in the peripheral perinuclear
area (a) and in the peripheral dendrite (b). Negative control results are shown
in (c). Scale bar: 0.2 µm.
Table I. Myosin V is present in a significantly higher number
in the subcortical region of the melanocyte
cpg per µm2a
Peripheral
Perinuclear perinuclear Center of Periphery of
Melanocyte area area the dendrite the dendrite
Melanocyte 1 1.6 11.5 6.8 8.8
Melanocyte 2 4.6 12.3 1.1 12.1
Melanocyte 3 13.4 19.6 11.0 13.9
Melanocyte 4 14.3 20.7 23.3 29.0
Melanocyte 5 6.0 13.0 11.2 12.9
Melanocyte 6 7.0 11.5 6.2 9.0
Mean 6 SEMb 7.8 6 2.0 14.8 6 1.7c 9.9 6 3.0 14.3 6 3.1c
Median 6.5 12.7 8.9 12.5
aThe background corrected number of myosin V colloidal gold particles per µm2 (cpg
per µm2) in four different melanocytic cytoplasmic regions.
bn 5 6.
cp , 0.005.
Myosin V colocalizes with the actin cytoskeleton For better
resolution the subcellular localization of myosin V was also determined
with immunoelectron microscopy. In all cultured skin cells, actin
immunoreactivity (5 nm gold particles) is prominent in the subcortical
region where actin is also morphologically recognizable as thin fila-
mentous bundles (Fig 6a). In the melanocytic dendrite actin bundles
are mainly localized in the periphery. Actin is less organized and less
present in the rest of the cytoplasm, e.g., in the organelle-rich
perinuclear area. In all these actin-rich areas there is a striking overlap
with myosin V staining (10 nm gold particles) and in the melanocytes,
colocalization of myosin V and actin is mainly seen in the periphery
of the dendrites (Fig 6b).
In control sections, only a few scattered gold particles were seen
(Fig 6c).
Quantitative analysis of myosin V labeling in the melanocyte revealed
a significantly higher (p , 0.005; see Table I) presence of myosin V
in the subcortical cell zone, i.e., in the periphery of the dendrite and
the peripheral perinuclear zone as compared with the center of the
dendrite and the perinuclear area.
In melanocytes, myosin V forms a link between melanosomes
and the actin cytoskeleton In addition to the colocalization with
actin, in all cells myosin V is occasionally seen in close association with
cytoplasmic membranous organelles that are not mitochondria. In the
melanocyte, double staining results using myosin V antibody and NKI-
beteb, a (pre)melanosomal marker, indicate colocalization (yellow
color) of myosin V with melanosomes in the perinuclear area and in
the dendrites (Fig 7). At the electron microscopic level, late stage
melanosomes are easily recognized as membrane-lined melanin-con-
taining vesicles. Several melanosomes located in the dendrites of
melanocytes colocalize with an actin bundle and myosin V, with
myosin V seen as an intermediate molecule between the melanosome
and an actin bundle (Fig 8a). Melanosomes also label with myosin V
without evidence for actin bundles in their neighborhood. Myosin V
specific gold particles are also seen on nonmelanized organelles in the
perinuclear area (Fig 8b). It remains to be investigated whether
these are early melanosomes (stage I melanosomes), Golgi-derived
melanogenesis-related coated vesicles, or other cytoplasmic organelles,
e.g., lysosomes. In the other skin cells (data not shown), myosin V can
also be seen in association with membrane-lined organelles.
DISCUSSION
Myosins are expressed in many different cell types and several different
myosin classes can occur in one cell type at the same time (Hasson
and Mooseker, 1996). The latter fact represents a problem when
performing hybridization assays for myosin V as unconventional myosins
display a high degree of sequence overlap, especially at the 59-end or
head region (Mooseker, 1993). Excluding significant sequence similarity
to any other known human myosin sequences in the GenBank
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Figure 7. Melanocytes show immunocolocalization of myosin V with
melanosomes. Fluorescence confocal photomicrographs represent single
labeling of (a) DIL-2 (myosin V antibody 1 tertiary fluorescein isothiocyanate-
conjugated), (b) NKI-beteb (anti-melanosome antibody 1 secondary Texas
red-conjugated), and (c) double labeling with both antibodies in a melanocyte.
Colocalization (yellow color; arrows) of melanosomes and myosin V occurs
mainly in the tips of dendrites and in the perinuclear area. Scale bar: 10 µm.
databases, we were able to provide the first evidence using RT-PCR
and northern blot analysis that myosin V is also expressed in human
epidermal melanocytes, keratinocytes, and dermal fibroblasts.
Northern blot expression and induction experiments were performed
in a basal medium (melanocyte growth medium) devoid of any cAMP-
inducers, as Nascimento et al (1997) and Wu et al (1997) recently
reported using western blot analysis that the cAMP signaling pathway
might regulate myosin V gene expression. Nascimento et al (1997)
detected a significant 4-fold stimulation of myosin V protein expression
after addition of IBMX/α-melanocyte stimulating hormone. Wu et al
(1997) saw at least two to three times as much myosin V in B16-F10
cells after stimulation with α-melanocyte stimulating hormone. Upon
stimulation of melanocytes with IBMX, an inhibitor of cAMP phospho-
diesterase, we repeatedly found an up to 5-fold increase of the relative
amount of myosin V message as compared with controls after 48 h;
however, we saw no effect of α-melanocyte stimulating hormone on
dendricity nor synergistic effect on the dendricity evoked by IBMX
(result not shown), similar to the results of Hedley et al (1998). Our
findings expand the hypothesis that myosin V expression is regulated
by the cAMP signaling pathway to the transcriptional level, at least at
this time point after stimulation.
Close association of myosin V with certain membranous organelles
in the organelle-rich perinuclear area and with melanosomes in
particular, suggests that myosin V might function more generally as an
organelle transporter. Its presence on fully melanized melanosomes,
early melanosomes, and lysosome-like organelles is in accordance with
findings in mice (early and late melanosomes) and with the fact that
lysosomes and melanosomes have a common origin (Orlow et al,
1993). Myosin V could interact with both organelles via the same
receptor/ligand structure. Its prominent presence in the tips of the
melanocytic dendrites might be an illustration of an active role in
melanosome transfer to surrounding keratinocytes, or it might just be
a reflection of its colocalization with actin bundles that show a highly
dynamic behavior at this leading edge. Simple concentration of
organelles at the narrow dendrite tips may also contribute.
Some authors (Provance et al, 1996; Wei et al, 1997) believe that
the primary event in dilute melanocytes is not the defective extension
of dendritic processes (because dendrites are present, though stubby
and underdeveloped), but is mainly a problem of melanosome move-
ment. The fact that dendrites are not fully extending could then be
secondary to the lack of stimulus from arriving melanosomes. On the
Figure 8. In melanocytes myosin V often colocalizes with actin and
melanosomes, but is also seen on nonmelanized organelles. Mature
melanosomes are easily recognized as the electron-dense oval structures. Myosin
V (10 nm gold particles) appears in association with an actin bundle (5 nm gold
particles) close to a melanosome (a). Myosin V is also seen on the membrane
of microvesicles (arrowheads) in the trans-Golgi network (b), possibly carrying
the post-Golgi melanogenic enzymes. Scale bar: 0.1 µm.
other hand, Wang et al (1996) do suggest a specific role for myosin V
in filopodial extension of chicken neuroneal growth cones, indicating
a possible role of myosin V in the extension of actin-rich processes,
e.g., by arranging the cytoskeletal actin. The presence of myosin V in
the subcortical actin meshwork in dendrites, in addition to the
observation that stimulation of melanocytes with IBMX is accompanied
by increased dendricity and that myosin V is at the same time
upregulated, suggest that myosin V may play a role in the reorganization
of actin bundles in the subcortical area. The colocalization of myosin
V with actin in the subcortical area, however, may just indicate
trafficking of myosin V along actin filaments, with or without an
attached organelle. Also, as the resulting differentiation of the melano-
cyte includes increased melanogenesis (Naeyaert et al, 1991; Hedley
et al, 1998), myosin V transcription and translation may be merely
induced because of the greater need for melanosome transport.
Next to the actin-based organelle movement system, the melanosome
translocation along microtubuli to specific destinations in the melano-
cyte also needs to be considered. Actin is located in the thick subcortical
meshwork in the peripheral dendrite, whereas microtubuli are present
in more central areas of the melanocyte like the organelle-rich
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perinuclear domain and the central dendrite area (Lacour et al, 1992;
Cole and Lippincott-Schwartz, 1995). One can indeed imagine a
complementary role for the actin-based and the microtubuli-based
cytoskeleton, with each system taking melanosome transport in a
particular region of the melanocyte into account. We observed that
melanosomes also label with myosin V in central cytoplasmic areas
where actin is less abundant and less organized. It could be that myosin
V, in these regions where microtubuli are described to be clearly
organized (Lacour et al, 1992), associates passively with melanosomes
that are at that point being transferred along microtubuli by their
respective motors. The two best-known microtubuli-associated motor
proteins kinesin and dynein have been shown to intervene in the
transport of membranous organelles in neurons (Pfister et al, 1989;
Hirokawa et al, 1990, 1991; Ferreira et al, 1992) and of pigment
granules in fish melanophores (Rodionov et al, 1991). Evidence for an
overlap in function is given by the fact that the yeast mutant myo2
phenotype can be suppressed by overexpression of a member of the
kinesin superfamily (Lillie and Brown, 1992). Furthermore, some
authors suggest that the gene product of the dilute suppressor gene in
mice that is capable of suppressing the phenotype of the dilute mutation
is possibly a kinesin (Moore et al, 1988).
In melanocytes of Griscelli patients and dilute mice another protein
completely taking over the myosin V function in melanosome transport
is obviously lacking; however, there is as yet no explanation for the
fact that the albinism is only partial, with normally pigmented skin
occurring next to hypopigmented patches and silvery-gray hair. These
findings suggest that the presumed important function of myosin V in
organelle transport might be taken over by another myosin or micro-
tubuli-associated motor protein with a redundant function, which
makes the search for the expression of other myosins and/or members
of the kinesin/dynein family most interesting. On the other hand the
role of myosin V might vary in importance between these different
cell types with a lower treshold to produce abnormal phenotypic
findings in the follicular melanocytes.
In conclusion, our findings support the hypothesis that myosin V
has an important function in melanosome transport. The mechanism
of myosin V activation to bind melanosomes and to direct their
movement remains to be elucidated. The eventual role of myosin V
in determining melanocyte dendricity and its possible role in the other
skin cells needs further examination.
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